Incidence and prognostic value of serotonin secretion in pancreatic neuroendocrine tumours

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Clinical Endocrinology

• Publication date

  2017-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/cen.13364PMID 28464233
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevalence and clinical features of the ectopic ACTH syndrome in patients with gastroenteropancreatic and thoracic neuroendocrine tumors.

  2016cited by this paper
• Multiple and Secondary Hormone Secretion in Patients With Metastatic Pancreatic Neuroendocrine Tumours.

  2016cited by this paper
• Limited value for urinary 5-HIAA excretion as prognostic marker in gastrointestinal neuroendocrine tumours.

  2016cited by this paper
• ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors

  2016cited by this paper
• Serotonin-Producing Tumor

  2015cited by this paper
• Parathyroid hormone-related peptide (PTHrP) secretion by gastroenteropancreatic neuroendocrine tumors (GEP-NETs): clinical features, diagnosis, management, and follow-up.

  2014cited by this paper
• Incidental diagnosis as prognostic factor in different tumor stages of nonfunctioning pancreatic endocrine tumors.

  2014cited by this paper
• Serial surveillance of carcinoid heart disease: factors associated with echocardiographic progression and mortality

  2014cited by this paper
• Comparison of 24-h and overnight samples of urinary 5-hydroxyindoleacetic acid in patients with intestinal neuroendocrine tumors

  2013cited by this paper
• The Association of a Panel of Biomarkers with the Presence and Severity of Carcinoid Heart Disease: A Cross-Sectional Study

  2013cited by this paper
• TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study.

  2012cited by this paper
• Incidental Detection of Pancreatic Neuroendocrine Tumors: An Analysis of Incidence and Outcomes

  2012cited by this paper
• A patient with a metastatic gastroenteropancreatic endocrine carcinoma causing hyperinsulinaemic hypoglycaemia and the carcinoid syndrome

  2011cited by this paper
• Serotonin-Producing Enterochromaffin Cell Tumors of the Pancreas: Clinicopathologic Study of 15 Cases and Comparison With Intestinal Enterochromaffin Cell Tumors

  2011cited by this paper
• Risk factors for the development and progression of carcinoid heart disease.

  2011cited by this paper
• Chromogranin A—Biological Function and Clinical Utility in Neuro Endocrine Tumor Disease

  2010cited by this paper
• Gastrointestinal Neuroendocrine Tumors

  2007cited by this paper
• Pathology Databanking and Biobanking in The Netherlands, a Central Role for PALGA, the Nationwide Histopathology and Cytopathology Data Network and Archive

  2007cited by this paper
• Carcinoids of the pancreas

  2005cited by this paper
• Pathology and genetics of tumours of endocrine organs

  2004cited by this paper
• An Analysis of Rare Carcinoid Tumors: Clarifying These Clinical Conundrums

  2004cited by this paper
• A 5‐decade analysis of 13,715 carcinoid tumors

  2003cited by this paper
• Factors associated with progression of carcinoid heart disease.

  2003cited by this paper
• Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients.

  2001cited by this paper
• Carcinoid syndrome, acromegaly, and hypoglycemia due to an insulin-secreting neuroendocrine tumor of the liver.

  2001cited by this paper
• Discriminating capacity of indole markers in the diagnosis of carcinoid tumors.

  2000cited by this paper
• Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center.

  1997cited by this paper
• Chromatography of urinary indole derivatives.

  1988cited by this paper
• Chromatography of urinary indole derivatives.

  1988cited by this paper
• Putting it together. The patient, the purse, and the practice.

  1977cited by this paper
• [METASTASIZING ISLET-CELL ADENOMA OF THE PANCREAS WITH PRODUCTION OF 5-HYDROXYTRYPTAMINE AND INSULIN].

  1964cited by this paper
• METASTASISING ISLET-CELL TUMOUR OF THE PANCREAS ASSOCIATED WITH HYPOGLYCAEMIA AND CARCINOID SYNDROME.

  1964cited by this paper
• Carcinoid syndrome due to pancreatic-duct neoplasm secreting 5-hydroxytryptophan and 5-hydroxytryptamine.

  1963cited by this paper

• Nonmetastatic Pulmonary Carcinoid Presenting With Carcinoid Syndrome Despite Negative 5‐HIAA: A Case Report

  2026cites this paper
• Serotonin (5‐Hydroxytryptamine): Metabolism, Signaling, Biological Functions, Diseases, and Emerging Therapeutic Opportunities

  2025cites this paper
• Pancreatic Neuroendocrine Tumor Associated with Carcinoid Heart Disease: A Case Report and Review of Literature

  2024cites this paper
• Epidemiology and Prognostic Nomogram for Predicting Long-Term Disease-Specific Survival in Patients With Pancreatic Carcinoid Tumor

  2024cites this paper
• Surgical Management of Pancreatic Neuroendocrine Tumors

  2023cites this paper
• European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes

  2023cites this paper
• Pancreatic Neuroendocrine Tumor (Pan-NET) Presented by Abdominal Pain: A Case Report and Literature Review

  2023influential citation
• A Case of Serotonergic Gastric Neuroendocrine Tumor with Fibrous Stroma an Unusual EUS Finding

  2022cites this paper
• Prognostic value of preoperative diabetes mellitus in patients with non-functional pancreatic neuroendocrine neoplasms.

  2022cites this paper
• Serotonin immunoreactive pancreatic neuroendocrine neoplasm associated with main pancreatic duct dilation: a recognizable entity with excellent long-term outcome

  2021cites this paper
• Vigilance for carcinoid heart disease is still required in the era of somatostatin analogues: Lessons from a case series

  2021cites this paper
• Prediction of recurrence after surgery based on preoperative MRI features in patients with pancreatic neuroendocrine tumors

  2021cites this paper
• Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets

  2021cites this paper
• The role of biomarker in pancreatic neuroendocrine tumor

  2021cites this paper
• Serotonin pathway in carcinoid syndrome: Clinical, diagnostic, prognostic and therapeutic implications

  2020cites this paper
• Management of refractory hypoglycaemia in a metastatic neuroendocrine tumour co-secreting serotonin and insulin

  2020cites this paper
• Serotonin-Secreting Neuroendocrine Tumours of the Pancreas

  2020cites this paper
• Workup of Gastroenteropancreatic Neuroendocrine Tumors.

  2020cites this paper
• Management of Diarrhea in Patients With Carcinoid Syndrome

  2019cites this paper
• Optimizing the Management of Carcinoid Syndrome to Reduce the Impact of Diarrhea

  2019cites this paper
• Pretreatment hematologic markers as prognostic predictors of gastroenteropancreatic neuroendocrine tumors: a systematic review and meta-analysis

  2018cites this paper
• Pretreatment hematologic markers as prognostic predictors of gastroenteropancreatic neuroendocrine tumors: a systematic review and meta-analysis

  2018cites this paper
• Supportive therapy in gastroenteropancreatic neuroendocrine tumors: Often forgotten but important

  2018cites this paper
• Effect of hormone secretory syndromes on neuroendocrine tumor prognosis.

  2017cites this paper
• Carcinoid-syndrome: recent advances, current status and controversies

  2017cites this paper
• The Diagnosis of Neuroendocrine Tumours: An Endocrine Perspective

  year unknowncites this paper